| Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method N Yao, W Xiao, X Wang, J Marik, SH Park, Y Takada, KS Lam Journal of medicinal chemistry 52 (1), 126-133, 2009 | 117 | 2009 |
| Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53 SH Park, JH Lee, JS Berek, MCT Hu International journal of oncology 45 (4), 1691-1698, 2014 | 102 | 2014 |
| FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage YM Chung, SH Park, WB Tsai, SY Wang, MA Ikeda, JS Berek, DJ Chen, ... Nature communications 3 (1), 1000, 2012 | 95 | 2012 |
| Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo JY Liu, SH Park, C Morisseau, SH Hwang, BD Hammock, RH Weiss Molecular cancer therapeutics 8 (8), 2193-2203, 2009 | 88 | 2009 |
| Rosmarinic acid inhibits TCR‐induced T cell activation and proliferation in an Lck‐dependent manner J Won, YG Hur, EM Hur, SH Park, MA Kang, Y Choi, C Park, KH Lee, ... European journal of immunology 33 (4), 870-879, 2003 | 88 | 2003 |
| The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma HJ Park, JS Bae, KM Kim, YJ Moon, SH Park, SH Ha, UK Hussein, ... Journal of Experimental & Clinical Cancer Research 37, 1-15, 2018 | 85 | 2018 |
| CK2α/CSNK2A1 phosphorylates SIRT6 and is involved in the progression of breast carcinoma and predicts shorter survival of diagnosed patients JS Bae, SH Park, U Jamiyandorj, KM Kim, SJ Noh, JR Kim, HJ Park, ... The American Journal of Pathology 186 (12), 3297-3315, 2016 | 81 | 2016 |
| Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance PY Lin, SP Fosmire, SH Park, JY Park, S Baksh, JF Modiano, RH Weiss Molecular cancer 6, 1-14, 2007 | 72 | 2007 |
| CK2α phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients JS Bae, SH Park, KM Kim, KS Kwon, CY Kim, HK Lee, BH Park, HS Park, ... International journal of cancer 136 (4), 797-809, 2015 | 71 | 2015 |
| Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK YS Hwang, YJ Kim, MO Kim, M Kang, SW Oh, YH Nho, SH Park, J Lee Chemico-Biological Interactions 273, 107-114, 2017 | 67 | 2017 |
| Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo SH Park, YM Chung, J Ma, Q Yang, JS Berek, MCT Hu Oncotarget 7 (27), 42110, 2016 | 57 | 2016 |
| Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications SH Park, KY Jang, MJ Kim, S Yoon, Y Jo, SM Kwon, KM Kim, KS Kwon, ... Oncotarget 6 (42), 44819, 2015 | 51 | 2015 |
| FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC KM Kim, SH Park, JS Bae, SJ Noh, GZ Tao, JR Kim, KS Kwon, HS Park, ... Scientific reports 7 (1), 3274, 2017 | 46 | 2017 |
| Beauvericin inhibits melanogenesis by regulating cAMP/PKA/CREB and LXR-α/p38 MAPK–mediated pathways SE Lee, SH Park, SW Oh, JA Yoo, K Kwon, SJ Park, J Kim, HS Lee, ... Scientific Reports 8 (1), 14958, 2018 | 44 | 2018 |
| High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers SH Park, X Wang, R Liu, KS Lam, RH Weiss Cancer Biology & Therapy 7 (12), 2015-2022, 2008 | 43 | 2008 |
| Melanogenic effects of maclurin are mediated through the activation of cAMP/PKA/CREB and p38 MAPK/CREB signaling pathways YS Hwang, SW Oh, SH Park, J Lee, JA Yoo, K Kwon, SJ Park, J Kim, E Yu, ... Oxidative medicine and cellular longevity 2019, 2019 | 42 | 2019 |
| Identification of acetylshikonin as the novel CYP2J2 inhibitor with anti-cancer activity in HepG2 cells SH Park, NM Phuc, J Lee, Z Wu, J Kim, H Kim, N doo Kim, T Lee, KS Song, ... Phytomedicine 24, 134-140, 2017 | 42 | 2017 |
| Ratiometric red-emission fluorescence detection of Al 3+ in pure aqueous solution and live cells by a fluorescent peptidyl probe using aggregation-induced emission LN Neupane, PK Mehta, S Oh, SH Park, KH Lee Analyst 143 (21), 5285-5294, 2018 | 41 | 2018 |
| FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas KM Kim, UK Hussein, SH Park, MA Kang, YJ Moon, Z Zhang, Y Song, ... Journal of Experimental & Clinical Cancer Research 38, 1-15, 2019 | 40 | 2019 |
| Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer R Liu, HI Wettersten, SH Park, RH Weiss Future medicinal chemistry 5 (9), 991-994, 2013 | 40 | 2013 |
Lee JongsungSungkyunkwan Universityskku.edu의 이메일 확인됨
